The Phivea™ Platform opens the door to future care and treatment of genetic disorders. Watch our brand new video on YouTube!
We are excited to announce that we have released a brand new video about the Phivea™ Platform, our innovative technology aiming to transform the diagnosis and treatment of genetic disorders.
Watch our colleagues Anne Kristine Schack, genomics researcher, and David Galevski, data scientist, guide you through the Phivea™ Platform, which we developed in strong collaboration with Netcetera, the University of Copenhagen and the Ss. Cyril and Methodius University in Skopje.
The Phivea™ Platform is a comprehensive decision support dashboard for healthcare professionals, which allows for timely diagnosis of genetic disorders and real-time prediction of clinical interventions. Phivea™ uses Oxford Nanopore Technology to classify genetic disorders and perform quality control on DNA reads. In particular, it allows real-time analysis of at least 384 samples simultaneously in less than 24 hours, meaning lower expenses for healthcare professionals and shorter path to diagnosis for patients. Phivea™ employs advanced Artificial Intelligence and customized Deep Learning architectures at all levels of the learning process, from feature extraction to assessment and follow-up care.
Watch our video on our gMendel® YouTube Channel.
22 Nov 2021gMendel is proud to announce that we have defined our QMS and are ready to move to product commercialisation.
17 Nov 2021AI enables unprecedented insights into how biomolecules work and thus advance the understanding of photoactive processes.
09 Nov 2021gMendel starts new partnerships with the SKEL AI Lab and the ahedd Digital Innovation Hub of the NCSR Demokritos, Greece
21 Oct 2021Watch our brand new video about the Phivea™ Platform, our innovative software, now LIVE on our YouTube Channel!